Pathology is an important part of medical care. It gives doctors the information they need to diagnose and treat patients. In the past few years, technology and science have changed how pathology is done. These changes affect how samples are studied across the United States. Medical practice managers, owners, and IT staff should understand these changes to make labs work better, be more accurate, and improve healthcare.
This article explains new tools in digital pathology, molecular diagnostics, and artificial intelligence (AI). It shows how these are changing pathology services today. It also talks about how using AI and automation can help labs work better and help teams work together more easily.
One clear change is moving from using physical glass slides to digital pathology. Before, pathologists looked at tissue samples on glass slides under microscopes. Now, digital pathology turns these slides into clear digital images. These images can be stored, shared, and studied using computers and special software.
Scanning slides in high detail lets pathologists review cases and ask other experts for help, even if they are far apart. This is very useful in the U.S., where experts are often spread across various hospitals and medical centers.
Companies like Aperio help with this by making slide scanning machines. The Aperio GT 450 DX scanner can process up to 450 slides fast. This helps busy labs handle many cases quickly. It makes clear images for fast and reliable diagnosis. Other models from Aperio, like the GT 450 or CS2, are designed for research, not clinical use.
Digital pathology also supports telepathology, which means pathologists can look at slides and give advice remotely. This improves access to expert opinions in places with few specialists. It was especially useful during the COVID-19 pandemic when travel was limited. Remote slide reviews allow labs to keep working no matter the distance.
Digital pathology changes the format for looking at tissues. Molecular pathology goes further by studying genes and molecules in diseases. Techniques like next-generation sequencing (NGS) look at DNA, RNA, and proteins in patient samples. This helps doctors understand how a disease works and choose treatments suited to each patient’s biology, called precision medicine.
Precision pathology helps with complex diseases such as cancer by showing detailed biomarker profiles. Immunohistochemistry (IHC) is still a key method here. It helps find specific proteins in tissues to classify disease, predict outcomes, and decide treatments. New digital tools improve how IHC images are checked, making the results more consistent by reducing differences between pathologists.
Applied Spectral Imaging (ASI) is a company working on combining digital pathology with genetic analysis. Their technology supports brightfield, fluorescence, and spectral imaging such as Fluorescence In Situ Hybridization (FISH). This helps detect biomarkers and analyze chromosomes. Their scanning systems automate image capturing and analysis, cutting down on manual work and boosting lab productivity.
AI and automation are becoming very important in handling the many tasks and data in U.S. labs. Labs get many samples and need accurate results. AI helps with routine work, highlights urgent cases, and improves diagnosis accuracy.
PathAI is a company working on AI in pathology. They added new features to their AISight platform:
These tools were made with advice from many U.S. pathologists, so they fit what labs need. Eric Walk from PathAI says these features help pathologists share knowledge and make workflows easier. This saves time for humans to work on more difficult parts instead of routine sorting and reviewing.
Automation also helps with capturing images and analyzing them. This is clear in cytogenetics, where counting chromosome signals or spotting metaphase spreads was done by hand. This took a lot of attention and time.
ASI’s Slide Loader and Metaphase Finder automate making digital metaphase images at night. This saves technologists from reviewing slides manually. They can spend more time interpreting results and writing reports. According to research by Anguiano and team, digital FISH analysis with ASI tools is more accurate and faster than old microscope methods.
Automation changes lab work from slow hand processes to faster, consistent digital work. This leads to better consistency, faster results, and fewer human mistakes.
Using AI in pathology goes beyond organizing work. AI models trained on millions of labeled images help pathologists find small details or guess how a patient might react to treatments. For example, PathAI’s models use over 15 million annotated images to make cancer diagnosis more accurate.
AI helps reduce differences between pathologists when interpreting complex stainings, like PD-L1 scoring. This score matters in deciding immunotherapy treatment. Dr. Lija Joseph from Lowell General Hospital said the ASI HiPath Pro system makes PD-L1 scoring more consistent, especially in hard cases with uneven staining.
These technologies bring pathology results closer to precise treatments, supporting personalized healthcare.
Many different tools and technologies are in use now. They need to work together. No single device or software can handle everything in a pathology lab. Connecting digital scanners, AI, laboratory systems (LIS), and electronic medical records (EMR) creates smooth workflows.
In the U.S., hospitals and medical centers use tools like Aperio scanners and PathAI’s AISight platform to manage cases and help with AI diagnosis. Some systems, like those from ASI, work with different scanners. This lets labs add new AI tools without changing their current equipment.
Also, virtual pathology networks let smaller or local labs get expert opinions from bigger centers. This helps keep pathology services steady and of good quality in different communities.
Those in charge of medical practices or labs need to know about current medical technology. Using digital pathology and AI means careful planning in areas like:
Paying attention to these helps labs work better while keeping accurate and high-quality diagnoses for patients.
The future of pathology in the U.S. is shaped by tools combining digital imaging, molecular tests, AI, and automated workflows. Digital scanners help process slides faster and allow remote teamwork. Molecular pathology gives deeper understanding of disease. AI systems make case management easier and improve accuracy. Automation cuts down on manual work, raising lab productivity.
These technologies help practice managers, owners, and IT teams improve pathology work in both clinical and research settings. They support faster and more accurate diagnoses. This ongoing change helps patients get better care and helps U.S. healthcare handle complex diseases more effectively.
AISight is a cloud-based digital pathology image management system that serves as a central hub for case management, image management, and AI integration, designed to enhance digital pathology workflows.
The new features are the Intelligent Caselist and AISight Live, which aim to optimize case review, collaboration, and pathology workflows through real-time interactions and efficient case prioritization.
AISight Live includes features that facilitate real-time collaboration such as a Sync view for slide navigation and a Participants list for inviting other pathologists to consult or review cases.
The Intelligent Caselist offers a streamlined view of case workloads with filterable charts and embedded AI to assist pathologists in prioritizing cases more efficiently.
The AISight platform was developed with input from hundreds of pathologists across various institutions, ensuring it meets the real needs of its users.
PathAI’s goal is to enhance patient outcomes through AI-powered pathology solutions that streamline workflows and allow pathologists to focus on critical aspects of patient care.
AISight is currently used by leading anatomic pathology laboratories, including reference and independent laboratories as well as academic medical centers.
No, AISight is designated for research use only and is not approved for diagnostic procedures.
PathAI manages one of the country’s largest anatomic pathology labs, located in Memphis, TN, which is CAP/CLIA-certified.
PathAI aims to provide comprehensive precision pathology solutions to optimize pathology sample analysis, improve interpretation accuracy, and enhance drug development for complex diseases.